• Return to Headlines

Bellicum Pharmac Has Returned 22.6% Since SmarTrend Recommendation (BLCM)

By Nick Russo

SmarTrend identified an Uptrend for Bellicum Pharmac (NASDAQ:BLCM) on February 27th, 2018 at $7.25. In approximately 2 months, Bellicum Pharmac has returned 22.57% as of today's recent price of $8.88.

Over the past year, Bellicum Pharmac has traded in a range of $5.02 to $23.11 and is now at $8.88, 77% above that low. Over the last five market days, the 200-day moving average (MA) has gone down 1.3% while the 50-day MA has declined 0.4%.

Bellicum Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company. The Company focuses on discovering and developing novel cellular immunotherapies for various forms of cancer. Bellicum Pharmaceuticals operates in the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Bellicum Pharmac shares.

Log in and add Bellicum Pharmac (BLCM) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights bellicum pharmac

Ticker(s): BLCM